Standardization of some herbal antidiabetic drugs in polyherbal formulation
Harinarayan Singh Chandel1,2★, A. K. Pathak2, Mukul Tailang3★ Corresponding author
- 1Truba Institute of Pharmacy, Karond Gandhi Nagar by pass Road, Bhopal-38, Madhya Pradesh;
- 2Department of Pharmacy, Barkatullah University, Bhopal-26, Madhya Pradesh;
- 3People's Institute of Pharmacy and Research centre, Bhopal-37, Madhya Pradesh, India
CORRESPONDENCE
Harinarayan Singh Chandel
*Address for correspondence: Prof. Harinarayan Singh Chandel, Truba Institute of Pharmacy, Karond Gandhi Nagar by pass Road, Bhopal - 462 038, Madhya Pradesh, India.
Revised: 27-07-2010.
Volume 3, Issue 1 · pp. 49–56 · PUBLISHED January 2011 · DOI: 10.4103/0974-8490.79116
View on Pharmacogn. Res. original site ↗
ABSTRACT
Background Ayurvedic formulations are used to treat a wide variety of diseases including diabetes mellitus Standardization of herbal formulation is essential in order to assess the quality of drugs. The present paper reports standardization of eight herbal anti-diabetic drugs−Momordica charantia (seeds), Syzigium cumini (seeds), Trigonella foenum (seeds), Azadirachta indica (leaves), Emblica offi cinalis (fruits), Curcuma longa (rhizomes), Gymnema sylvestre (leaves), Pterocarpus marsupium (heart-wood) individually and in polyherbal marketed samples of Baidyanath Madhumehari Churna Material and Methods Shivayu Madhuhari Churna, Meghdut Madhushoonya Churna and were compared to the in-house preparation for physicochemical properties. Results and Conclusions The limits obtained from the different physicochemical parameters of the individual eight herbal drugs and the marketed formulations could be used as reference standard for standardization of the anti-diabetic drugs in a quality control laboratory.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Chandel, H. S., Pathak, A. K., & Tailang, M. (2011). Standardization of some herbal antidiabetic drugs in polyherbal formulation. Pharmacognosy Research, 3(1), 49–56. https://doi.org/10.4103/0974-8490.79116
